Literature DB >> 30181160

SRY-Box Containing Gene 4 Promotes Liver Steatosis by Upregulation of SREBP-1c.

Yang Jiao1, Jiejie Zhao1,2, Zhijian Zhang3, Min Li1, Xi Yu1, Yanying Yang1, Jie Liu4, Shengjie Liao4, Duanzhuo Li4, Yuxing Wang4, Die Zhang4, Yulu Chen4, Guojun Shi5, Bin Liu6,4, Yan Lu6, Xiaoying Li6.   

Abstract

Obesity is usually associated with an increased risk of nonalcoholic fatty liver disease that is characterized by accumulation of excessive triglyceride (TG) in hepatocytes. However, the factors involved in the obesity-induced hepatosteatosis are poorly defined. Here, we report that SRY-box containing gene 4 (Sox4), a transcription factor that regulates cell proliferation and differentiation, plays an important role in hepatic TG metabolism. Sox4 expression levels are markedly upregulated in livers of obese rodents and humans. Adenovirus-medicated overexpression of Sox4 in the livers of lean mice promotes liver steatosis, whereas liver-specific knockdown of Sox4 ameliorates TG accumulation and improves insulin resistance in obese mice. At the molecular level, we show that Sox4 could directly control the transcription of SREBP-1c gene through binding to its proximal promoter region. Thus, we have identified Sox4 as an important component of hepatic TG metabolism.
© 2018 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30181160     DOI: 10.2337/db18-0184

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  4 in total

1.  Apobec1 complementation factor overexpression promotes hepatic steatosis, fibrosis, and hepatocellular cancer.

Authors:  Valerie Blanc; Jesse D Riordan; Saeed Soleymanjahi; Joseph H Nadeau; ILKe Nalbantoglu; Yan Xie; Elizabeth A Molitor; Blair B Madison; Elizabeth M Brunt; Jason C Mills; Deborah C Rubin; Irene O Ng; Yeonjung Ha; Lewis R Roberts; Nicholas O Davidson
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

2.  Comparison of hepatic gene expression profiles between three mouse models of Nonalcoholic Fatty Liver Disease.

Authors:  Liping Xiang; Yang Jiao; Yiling Qian; Yao Li; Fei Mao; Yan Lu
Journal:  Genes Dis       Date:  2021-02-27

3.  Isochlorogenic Acid C Alleviates High-Fat Diet-Induced Hyperlipemia by Promoting Cholesterol Reverse Transport.

Authors:  Liuyi Zheng; Guangyao Lin; Ruyue Li; Haining Gan; Xuejun Huang; Nan Yao; Dake Cai; Ziming Zhao; Zixuan Hu; Minyi Li; Huazhen Xu; Leyi Li; Sha Peng; Xinxin Zhao; Yijing Lai; Yuxing Chen; Dane Huang
Journal:  Front Pharmacol       Date:  2022-07-25       Impact factor: 5.988

4.  Paeoniflorin alleviates liver injury in hypercholesterolemic rats through the ROCK/AMPK pathway.

Authors:  Tong Liu; Ning Zhang; Lingya Kong; Sijie Chu; Ting Zhang; Guangdi Yan; Donglai Ma; Jun Dai; Zhihong Ma
Journal:  Front Pharmacol       Date:  2022-08-23       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.